BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29679507)

  • 21. Wnt/β-catenin signaling mediates both heart and kidney injury in type 2 cardiorenal syndrome.
    Zhao Y; Wang C; Hong X; Miao J; Liao Y; Hou FF; Zhou L; Liu Y
    Kidney Int; 2019 Apr; 95(4):815-829. PubMed ID: 30770217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific Inhibitor of Smad3 (SIS3) Attenuates Fibrosis, Apoptosis, and Inflammation in Unilateral Ureteral Obstruction Kidneys by Inhibition of Transforming Growth Factor β (TGF-β)/Smad3 Signaling.
    Ji X; Wang H; Wu Z; Zhong X; Zhu M; Zhang Y; Tan R; Liu Y; Li J; Wang L
    Med Sci Monit; 2018 Mar; 24():1633-1641. PubMed ID: 29555895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wnt/β-catenin regulates blood pressure and kidney injury in rats.
    Xiao L; Xu B; Zhou L; Tan RJ; Zhou D; Fu H; Li A; Hou FF; Liu Y
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1313-1322. PubMed ID: 30710617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetyl-11-keto-β-boswellic acid ameliorates renal interstitial fibrosis via Klotho/TGF-β/Smad signalling pathway.
    Liu M; Liu T; Shang P; Zhang Y; Liu L; Liu T; Sun S
    J Cell Mol Med; 2018 Oct; 22(10):4997-5007. PubMed ID: 30054990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smad3 deficiency attenuates renal fibrosis, inflammation,and apoptosis after unilateral ureteral obstruction.
    Inazaki K; Kanamaru Y; Kojima Y; Sueyoshi N; Okumura K; Kaneko K; Yamashiro Y; Ogawa H; Nakao A
    Kidney Int; 2004 Aug; 66(2):597-604. PubMed ID: 15253712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Klotho Ameliorates Kidney Injury and Fibrosis and Normalizes Blood Pressure by Targeting the Renin-Angiotensin System.
    Zhou L; Mo H; Miao J; Zhou D; Tan RJ; Hou FF; Liu Y
    Am J Pathol; 2015 Dec; 185(12):3211-23. PubMed ID: 26475416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural flavonoid pectolinarigenin alleviated kidney fibrosis via inhibiting the activation of TGFβ/SMAD3 and JAK2/STAT3 signaling.
    Li Y; Guo F; Huang R; Ma L; Fu P
    Int Immunopharmacol; 2021 Feb; 91():107279. PubMed ID: 33340783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition.
    Hu N; Duan J; Li H; Wang Y; Wang F; Chu J; Sun J; Liu M; Wang C; Lu C; Wen A
    PLoS One; 2016; 11(4):e0153409. PubMed ID: 27088510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concomitant inhibition of renin angiotensin system and Toll-like receptor 2 attenuates renal injury in unilateral ureteral obstructed mice.
    Chung S; Jeong JY; Chang YK; Choi DE; Na KR; Lim BJ; Lee KW
    Korean J Intern Med; 2016 Mar; 31(2):323-34. PubMed ID: 26932402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential therapeutic efficacy of pachymic acid in chronic kidney disease induced in rats: role of Wnt/β-catenin/renin-angiotensin axis.
    Younis NN; Mohamed HE; Shaheen MA; Abdelghafour AM; Hammad SK
    J Pharm Pharmacol; 2022 Jan; 74(1):112-123. PubMed ID: 34549301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Matrix Metalloproteinase-13 Inhibitor Poricoic Acid ZI Ameliorates Renal Fibrosis by Mitigating Epithelial-Mesenchymal Transition.
    Chen L; Cao G; Wang M; Feng YL; Chen DQ; Vaziri ND; Zhuang S; Zhao YY
    Mol Nutr Food Res; 2019 Jul; 63(13):e1900132. PubMed ID: 30925007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3.
    Li J; Qu X; Ricardo SD; Bertram JF; Nikolic-Paterson DJ
    Am J Pathol; 2010 Sep; 177(3):1065-71. PubMed ID: 20651248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elsholtzia ciliata (Thunb.) Hylander attenuates renal inflammation and interstitial fibrosis via regulation of TGF-ß and Smad3 expression on unilateral ureteral obstruction rat model.
    Kim TW; Kim YJ; Seo CS; Kim HT; Park SR; Lee MY; Jung JY
    Phytomedicine; 2016 Apr; 23(4):331-9. PubMed ID: 27002403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease.
    Choi HS; Song JH; Kim IJ; Joo SY; Eom GH; Kim I; Cha H; Cho JM; Ma SK; Kim SW; Bae EH
    Sci Rep; 2018 Aug; 8(1):11546. PubMed ID: 30068917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
    Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
    J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wnt/β-catenin signaling and renin-angiotensin system in chronic kidney disease.
    Zhou L; Liu Y
    Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):100-6. PubMed ID: 26808707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dimethylfumarate attenuates renal fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling.
    Oh CJ; Kim JY; Choi YK; Kim HJ; Jeong JY; Bae KH; Park KG; Lee IK
    PLoS One; 2012; 7(10):e45870. PubMed ID: 23056222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Notch γ-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-β/Smad2/3 signaling pathway activation.
    Xiao Z; Zhang J; Peng X; Dong Y; Jia L; Li H; Du J
    Int J Biochem Cell Biol; 2014 Oct; 55():65-71. PubMed ID: 25150830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction.
    Sato M; Muragaki Y; Saika S; Roberts AB; Ooshima A
    J Clin Invest; 2003 Nov; 112(10):1486-94. PubMed ID: 14617750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HGF alleviates renal interstitial fibrosis via inhibiting the TGF-β1/SMAD pathway.
    Xu J; Yu TT; Zhang K; Li M; Shi HJ; Meng XJ; Zhu LS; Zhu LK
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7621-7627. PubMed ID: 30536302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.